Unique ID issued by UMIN | UMIN000020977 |
---|---|
Receipt number | R000024207 |
Scientific Title | preoperative gemcitabine based chemoradiation therapy for resectable and borderline resectable pancreatic cancer phase1 study |
Date of disclosure of the study information | 2016/04/01 |
Last modified on | 2021/08/15 22:17:46 |
preoperative gemcitabine based chemoradiation therapy for resectable and borderline resectable pancreatic cancer phase1 study
Preoperative chemoradiation therapy for pancreatic cancer
preoperative gemcitabine based chemoradiation therapy for resectable and borderline resectable pancreatic cancer phase1 study
Preoperative chemoradiation therapy for pancreatic cancer
Japan |
resectable and borderline resectable pancreatic cancer
Hepato-biliary-pancreatic surgery | Radiology |
Malignancy
NO
To evaluate safety of preoperative gemcitabine based chemoradiation therapy for pancreatic cancer.
Safety
Phase I
occurrence of side effect of preoperative gemcitabine based chemoradiation therapy
postoperative complication, 2-year recurrence-free survival, 2-year overall survival, recurrence site
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine | Other |
gemcitabine (1000mg/m2) treated on day1,8,15,29,36,43,57,64,71
radiation thrapy;54gly(1.8Gly * 30days)
20 | years-old | <= |
80 | years-old | > |
Male and Female
1) histopathologically diagnosed pancreatic cancer
2) performance status: 0-1 (eco grade)
3) pancreatic cancer, diagnosed as resectable by enhanced computed tomography
4) patient who expected to have more than 6 month survival at start of the treatment
5) patient with normal organ function
white blood cell:>3500/mm3,<10,000/mm3
neutrophil: >2,000/mm3
lymphocyte: >1,500/mm3
platelet: >100,000/mm3
hemoglobin: >9.0g/dl
total bilirubin: <2.0mg/dl
ast, alt:>150 u/l
serum creatinine:<1.2mg/dl
1) unresectable pancreatic cancer
1 distant organ metastasis
2 peritoneal dissamination
3 para aortic lymph node metastasis
4 pancreatic cancer with artery invasion, such as abdominal aorta, superior mesenteric artery, ceriac artery, common hepatic artery, or proper hepatic artery.
5 portal vein invasion beyond reconstruction
patient with interstitial lung disease or fibroid lung
patient with severe diarrhea
active viral infection excluding viral hepatitis
patient with double cancer
a woman of childbearing potential
patient with severe psychological disorder
patient with severe allergy to any drug
10
1st name | Shigeru |
Middle name | |
Last name | Marubashi |
Fukushima medical university
Division of Hepato-Biliary-Pancreatic and Transplant surgery
9601295
fukushima hikarigaoka 1
024-547-1111
mgotoh@fmu.ac.jp
1st name | Naoya |
Middle name | |
Last name | sato |
Fukushima medical university
Division of Hepato-Biliary-Pancreatic and Transplant surgery
9601295
fukushima hikarigaoka 1
024-547-1111
nawoya2U@gmail.com
fukushima medical university
fukusima medical university
department of regenerative surgery
Other
Fukushima medical university
Fukushima Hikarigaoka-1
0245471254
nawoya@fmu.ac.jp
NO
福島県立医科大学附属病院
2016 | Year | 04 | Month | 01 | Day |
Unpublished
30
No longer recruiting
2016 | Year | 02 | Month | 10 | Day |
2016 | Year | 04 | Month | 01 | Day |
2016 | Year | 04 | Month | 01 | Day |
2021 | Year | 02 | Month | 01 | Day |
2021 | Year | 02 | Month | 28 | Day |
2021 | Year | 10 | Month | 01 | Day |
2016 | Year | 02 | Month | 10 | Day |
2021 | Year | 08 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024207
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |